Transactions
September 5 2017
KippsDeSanto & Co. Advises JBS International, Inc. on its Sale to BlueCross BlueShield of South Carolina
KippsDeSanto & Co. is pleased to announce the sale of our client, JBS International, Inc. (“JBS” or the “Company”) to BlueCross BlueShield of South Carolina (“BCBSSC”).
Headquartered in Rockville, MD, JBS is a provider of public health and social impact solutions focused on projects in support of critical Department of Health and Human Services (“HHS”) and other civilian agency, state government, and non-profit programs that enhance and protect the health and well-being of individuals and populations. JBS plays a leading role in programs that are driving change in areas such as addiction and recovery, children and families, health IT, public health, workforce and education, and international development. The Company provides a combination of consulting, professional, and information technology (“IT”) services to deliver innovative solutions for policy and program development, communications and integrated marketing, strategic planning, and survey research and evaluation.
BCBSSC, one of the most successful and respected BlueCross BlueShield plans in the country, acquired JBS in order to expand the capabilities and customer reach of The Celerian Group. The Celerian Group is a portfolio of healthcare companies owned by BCBSSC, representing over 5,000 dedicated and trusted employees, that supports healthcare administration for the Federal government.
We believe this transaction demonstrates several key trends in the government and healthcare M&A environment:
• Deep domain and subject matter expertise, particularly when coupled with long-term relationships, are critical differentiators for sellers in a crowded M&A market
• Companies at the forefront of growing national and international health crises, such as the opioid epidemic, represent opportunities to achieve positive impact on multiple levels (the so-called “double bottom line”).
• The marketplace remains bullish for companies that are positioned with prime contracts that are ali
LEAD INVESTMENT BANKERS
Kevin P. DeSanto
KippsDeSanto & Co. is pleased to announce the sale of our client, JBS International, Inc. (“JBS” or the “Company”) to BlueCross BlueShield of South Carolina (“BCBSSC”).
Headquartered in Rockville, MD, JBS is a provider of public health and social impact solutions focused on projects in support of critical Department of Health and Human Services (“HHS”) and other civilian agency, state government, and non-profit programs that enhance and protect the health and well-being of individuals and populations. JBS plays a leading role in programs that are driving change in areas such as addiction and recovery, children and families, health IT, public health, workforce and education, and international development. The Company provides a combination of consulting, professional, and information technology (“IT”) services to deliver innovative solutions for policy and program development, communications and integrated marketing, strategic planning, and survey research and evaluation.
BCBSSC, one of the most successful and respected BlueCross BlueShield plans in the country, acquired JBS in order to expand the capabilities and customer reach of The Celerian Group. The Celerian Group is a portfolio of healthcare companies owned by BCBSSC, representing over 5,000 dedicated and trusted employees, that supports healthcare administration for the Federal government.
We believe this transaction demonstrates several key trends in the government and healthcare M&A environment:
• Deep domain and subject matter expertise, particularly when coupled with long-term relationships, are critical differentiators for sellers in a crowded M&A market
• Companies at the forefront of growing national and international health crises, such as the opioid epidemic, represent opportunities to achieve positive impact on multiple levels (the so-called “double bottom line”).
• The marketplace remains bullish for companies that are positioned with prime contracts that are ali
LEAD INVESTMENT BANKERS
Kevin P. DeSanto
We prioritize your privacy. We do not sell your information and will only send occasional, relevant emails.
Copyright © 2025 KippsDeSanto & Co.
All Rights Reserved